Issued Patents All Time
Showing 101–125 of 143 patents
| Patent # | Title | Co-Inventors | Date |
|---|---|---|---|
| 5905145 | Isolated nucleic acid molecules which encode TAGE molecules, and uses thereof | Pierre van der Bruggen | 1999-05-18 |
| 5886145 | Isolated nucleic acid molecules, peptides which form complexes with MHC molecule HLA-A2 and uses thereof | Yannick Guilloux, Francine Jotereau, Sophie Lucas, Vincent Brichard | 1999-03-23 |
| 5879892 | Leukemia associated genes | Nicolas Van Baren, Pierre Coulie, Charles DeSmet, Sophie Lucas | 1999-03-09 |
| 5877017 | Isolated nucleic acid molecule encoding peptides which form complexes with MHC molecule HLA-Cw*1601 and uses thereof | Pascale Boel, Claude Wildmann, Pierre van der Bruggen, Pierre Coulie, Jean-Christophe Renauld | 1999-03-02 |
| 5858689 | Isolated peptides derived from the gage tumor rejection antigen precursor and uses thereof | Pierre van der Bruggen, Benoit Van den Eynde, Olivier DeBacker | 1999-01-12 |
| 5856091 | Isolated nucleic acid sequence coding for a tumor rejection antigen precursor processed to at least one tumor rejection antigen presented by HLA-A2 | Vincent Brichard, Aline Van Pel, Catia Traversari, Thomas Wolfel, Pierre Coulie +1 more | 1999-01-05 |
| 5854203 | Tumor rejection antigen precursor processed to at least one tumor rejection antigen presented by HLA-A2 | Vincent Brichard, Aline Van Pel, Catia Traversari, Thomas Wolfel, Etienne De Plaen | 1998-12-29 |
| 5851523 | Isolated, peptides derived from MAGE tumor rejection antigen precursors which complex with HLA-A2 molecules and uses thereof | Alan Townsend, Judy Bastin, Pierre van der Bruggen, Pierre Coulie, Thomas F. Gajewski | 1998-12-22 |
| 5846826 | Isolated cytolytic T cell line specific to complexes of HLA-B44 molecules and specific nonapeptides | Pierre Coulie | 1998-12-08 |
| 5843688 | Isolated tyrosinase derived peptides and uses thereof | Thomas Wolfel, Aline Van Pel, Vincent Brichard, Etienne DePlaen, Pierre Coulie +2 more | 1998-12-01 |
| 5843687 | Isolated, tyrosinase derived peptides and uses thereof | Thomas Wolfel, Aline Van Pel, Vincent Brichard | 1998-12-01 |
| 5837476 | Methods for determining disorders by assaying for a non-tyrosinase, tumor rejection antigen precursor | Vincent Brichard, Aline Van Pel, Catia Traversari, Thomas Wolfel, Etienne De Plaen | 1998-11-17 |
| 5830753 | Isolated nucleic acid molecules coding for tumor rejection antigen precursor dage and uses thereof. | Pierre Coulie, Hideyuki Ikeda | 1998-11-03 |
| 5821122 | Isolated nucleic acid molecules, peptides which form complexes with MHC molecule HLA-A2 and uses thereof | Yannick Guilloux, Francine Jotereau, Sophie Lucas, Vincent Brichard | 1998-10-13 |
| 5763165 | Method for determining lung adenocarcinomas by assaying for one or more of MAGE-1, MAGE-2 and MAGE-3 | Patrick Weynants, Bernard Lethe, Francis Brasseur, Marie Marchand, Charles DeSmet +3 more | 1998-06-09 |
| 5763155 | Method for determining lung adenocarcinomas by assaying for one or more of MAGE-1, MAGE-2 and MAGE-3 gene products | P. Weynants, Bernard Lethe, Francis Brasseur, M. Patrick Marchand, Charles DeSmet +3 more | 1998-06-09 |
| 5759783 | Method of screening for cancer by detecting messenger RNA for a MAGE-XP gene | Christophe Lurquin, Francis Brasseur | 1998-06-02 |
| 5747271 | Method for identifying individuals suffering from a cellular abnormality some of whose abnormal cells present complexes of HLA-A2/tyrosinase derived peptides, and methods for treating said individuals | Vincent Brichard, Aline Van Pel, Etienne De Plaen, Pierre Coulie, Jean-Christope Renauld +1 more | 1998-05-05 |
| 5744353 | Cytolytic T cell lines which bind to complexes of tumor rejection antigens and HLA-B44 molecules | Jean Herman, Pierre Coulie, Pierre van der Bruggen, Immanuel F. Luescher | 1998-04-28 |
| 5744316 | Isolated, tyrosinase derived peptides and uses thereof | Bernard Lethe, Vincent Brichard, Aline Van Pel, Thomas Wolfel | 1998-04-28 |
| 5695994 | Isolated cytolytic T cells specific for complexes of MAGE related peptides and HLA molecules | Pierre van der Bruggen, Etienne De Plaen, Christophe Lurguin, Catia Traversari, Beatrice Gaugler +1 more | 1997-12-09 |
| 5686068 | Isolated peptides derived from MAGE-2, cytolytic T cells specific to complexes of peptide and HLA-A2 molecules, and uses thereof | Cornelius Melief, M. W. Visseren, Sjoerd Henricus Van Der Burg, Pierre van der Bruggen | 1997-11-11 |
| 5683886 | Tumor rejection antigens which correspond to amino acid sequences in tumor rejection antigen precursor bage, and uses thereof | Pierre van der Bruggen | 1997-11-04 |
| 5648226 | Isolated peptides derived from tumor rejection antigens, and their use | Benoit Van den Eynde, Olivier DeBacker | 1997-07-15 |
| 5629166 | Method for identifying individuals suffering from a cellular abnormality some of whose abnormal cells present complexes of HLA-C-clone 10/MAGE-1 derived peptides, and methods for treating said individuals | Pierre van der Bruggen | 1997-05-13 |